Methods of using beta glucan as a radioprotective agent
US8563531B2 · kind B2 · utility
1Cited by
52References
26Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Jul 8, 2008 |
| Grant date | Oct 22, 2013 |
| Priority date | — |
| Expiry date | Dec 3, 2030 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention relates to methods for treating and preventing radiation and/or chemotherapy related injury and/or afflictions, such as myelosuppression and decreased macrophage activity, by administering a prophylactically or therapeutically effective amount of particulate, bioavailable β(1,3; 1,6) glucan. The invention also relates to methods in which β(1,3; 1,6) glucan is provided in the form of whole glucan particles, microparticulate β-glucan particles or a combination thereof.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.